Showing results (11-20 of 33) with videos related to

Sort By:
Pageof 4
Epigenetics|January 17, 2013
Time- and residue-specific differences in histone acetylation induced by VPA and SAHA in AML1/ETO-positive leukemia cellsValentina Barbetti, Antonella Gozzini, Giulia Cheloni, et al.
Stem Cells International|November 10, 2017
The Leukemic Stem Cell Niche: Adaptation to "Hypoxia" versus Oncogene AddictionGiulia Cheloni, Martina Poteti, Silvia Bono, et al.
The Journal of Clinical Investigation|August 9, 2014
Arachidonate 15-lipoxygenase is required for chronic myeloid leukemia stem cell survivalYaoyu Chen, Cong Peng, Sheela A Abraham, et al.
Blood|June 4, 2017
Targeting chronic myeloid leukemia stem cells with the hypoxia-inducible factor inhibitor acriflavineGiulia Cheloni, Michele Tanturli, Ignazia Tusa, et al.
Cell Cycle (Georgetown, Tex.)|December 9, 2014
The metabolically-modulated stem cell niche: a dynamic scenario regulating cancer cell phenotype and resistance to therapyElisabetta Rovida, Silvia Peppicelli, Silvia Bono, et al.
Targeted Oncology|August 12, 2020
In Vitro Comparison of the Effects of Imatinib and Ponatinib on Chronic Myeloid Leukemia Progenitor/Stem Cell FeaturesIgnazia Tusa, Giulia Cheloni, Martina Poteti, et al.
Stem Cell Reports|September 25, 2018
Targeting the Extracellular Signal-Regulated Kinase 5 Pathway to Suppress Human Chronic Myeloid Leukemia Stem CellsIgnazia Tusa, Giulia Cheloni, Martina Poteti, et al.
Cancers|September 10, 2021
Glutamine Availability Controls BCR/Abl Protein Expression and Functional Phenotype of Chronic Myeloid Leukemia Cells Endowed with Stem/Progenitor Cell PotentialMartina Poteti, Giulio Menegazzi, Silvia Peppicelli, et al.
Cancer Discovery|September 16, 2016
Chronic Myelogenous Leukemia- Initiating Cells Require Polycomb Group Protein EZH2Huafeng Xie, Cong Peng, Jialiang Huang, et al.
Cancer Immunology, Immunotherapy : CII|July 14, 2022
Personalized tumor vaccine for pancreatic cancerShira Orr, Ling Huang, James Moser, et al.
Pageof 4